CHU de Liege /ID# 270223

Liège 4000

0 studies enrolling now · 1 studies all time

What they study most

Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma

Studies at this site

• A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma — Running, not enrolling